Quantbot Technologies LP Ab Cellera Biologics Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$5.66 - $7.59 $112,237 - $150,509	-19,830 Reduced 22.89%	66,799 $431,000
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $507,438 - $776,082	69,417 Added 403.31%	86,629 $653,000
Q4 2022 Feb 13, 2023	SELL	$9.48 - $14.52 $656,471 - $1.01 Million	-69,248 Reduced 80.09%	17,212 $174,000
Q3 2022 Nov 07, 2022	BUY	$9.2 - $13.68 $196,429 - $292,081	21,351 Added 32.79%	86,460 $855,000
Q2 2022 Aug 09, 2022	BUY	$5.72 - $10.65 $372,423 - $693,410	65,109 New	65,109 $693,000
Q2 2021 Aug 12, 2021	SELL	$20.19 - $34.17 $8,782 - $14,863	-435 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $10,131 - $23,142	435 New	435 $14,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.